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Abstract
This project considers how one might augment a limited amount of
data from randomized controlled trial (RCT) with more plentiful data
from an observational database (ODB), in order to estimate a causal effect.
In our motivating setting, the ODB has better external validity, while the
RCT has genuine randomization. We work with strata defined by the
propensity score in the ODB. Subjects from the RCT are placed in strata
defined by the propensity they would have had, had they been in the ODB.
Our first method simply spikes the RCT data into their corresponding
ODB strata. Our second method takes a data driven convex combination
of the ODB and RCT treatment effect estimates within each stratum.
Using the delta method and simulations we show that the spike-in method
works best when the RCT covariates are drawn from the same distribution
as in the ODB. Our convex combination method is more robust than the
spike-in to covariate-based inclusion criteria that bias the RCT data. We
apply our methods to data from the Women’s Health Initiative, a study
of thousands of postmenopausal women which has both observational and
experimental data on hormone therapy (HT). Using half of the RCT to
define a gold standard, we find that a version of the spiked-in estimate
yields stable estimates of the causal impact of HT on coronary heart
disease.
1 Introduction
The increasing availability of large, observational datasets poses opportunities
and challenges for statistical methodologists. These datasets often “contain de-
tailed information about the target population of interest,” meaning they could
have great utility for estimating the causal effects of a proposed intervention,
such as a public health initiative (Hartman et al., 2013). Yet assignment to
the treatment is non-random in these data, making standard methods prone to
misstate the treatment effect.
Randomized control trials (RCTs) make causal inference substantially eas-
ier, because the researcher controls assignment of the intervention. Yet RCTs
present their own challenges. A commonly raised concern is that “estimates
from RCTs . . . may lack external validity” (Hartman et al., 2013) due to the
sampling scheme used to enroll participants. Moreover, in cases where the treat-
ment effect varies by subpopulation, “experiments have to be very large and, in
general, prohibitively costly” whereas “observational data is often available in
much larger quantities” (Peysakhovich and Lada, 2016).
These issues motivate a hybrid approach, which makes use of the availability,
size, and representativeness of observational data as well as the randomization
inherent in RCT data. Implicitly, any such approach will also involve combining
biased and unbiased estimators – a problem with substantial precedent in the
literature (??). The fundamental tool used in our approach is the propensity
score: the estimated conditional probability of exposure to the intervention,
given observed covariates.
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Rosenbaum and Rubin (1984) showed that comparing treated individuals
against control individuals for whom the propensity score is approximately equal
yields a substantial reduction in bias. The propensity score is widely used in
analysis of observational datasets, as comparing test and control units with
similar propensity scores “tends to balance observed covariates that were used to
construct the score” (Joffe and Rosenbaum, 1999). It has been less widely used
in the context of RCTs. But propensity-based methods “have been shown to be
useful even in randomized control settings, where the assignment mechanism is
known and independent of the covariates” (Xu and Kalbfleisch, 2010), because
they correct for chance imbalance in covariates.
In using the propensity score, we make several simplifying assumptions: we
assume a strongly ignorable treatment assignment (SITA), as defined by Rosen-
baum and Rubin (1984); and we allow for a heterogeneous treatment effect but
assume that it varies only as a function of the propensity. Both are strong as-
sumptions. The existence of a prospectively designed RCT in our setting may
yield some insights into the factors affecting treatment assignment in the ODB,
lending some additional plausibility to the SITA assumption. Yet it remains
hard to defend in practice, and a natural extension of this work will involve
engaging with unmeasured confounders.
The latter assumption is retained in its strictest form for simplicity, but
can be greatly weakened by sub-stratifying on additional features assumed to
be related to the heterogeneity of the treatment effect. A practical example
is provided in Section 5.4. The treatment effect for subjects in the RCT is
assumed to be the same function of the propensity that holds in the ODB. The
distribution of covariates in the RCT can however be much different from the
ODB due to factors such as varying enrollment criteria.
We assume that the covariate distribution in the ODB is the same as that
of the target population. We use data from the RCT to provide much-needed
control subjects in the strata with a high propensity in the ODB as well as test
group subjects in the strata with a low propensity in the ODB. Note that this is
a relatively simple case of causal transportability, as, per the discussion above,
we assume the propensity score is a causal modifier and that other modifiers are
known via subject matter expertise. We are also not engaging with the question
of selection diagrams, and implicitly making strong invariance assumptions (?).
Our two main estimators are a spiked-in estimator that simply merges the
ODB and RCT within each stratum and a “dynamically weighted” estimator
that mimics the best possible convex combination of estimates from the two
populations, within each stratum.
The remainder of the paper is organized as follows. In Section 2, we define
our notation, assumptions, estimand and estimators, including the spiked-in
and dynamic weighting estimators that we propose. We work in the potential
outcomes framework, in which treatment effects are ratio estimators due to
the random numbers of subjects in each condition. For the large sample sizes
of interest to us, delta method approximations to the mean and variance are
accurate enough. Section 3 presents delta method estimates of the within-
stratum bias and variance for our estimators. There we see theoretically that
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the spiked-in estimator can have an enormous bias if the covariates in the RCT
do not follow the same distribution as those of the ODB.
Section 4 gives some numerical illustrations of our method for an ODB of size
5,000 and an RCT of size 200. When the RCT covariates follow the ODB’s dis-
tribution, then the spiked-in estimator brings a large reduction in mean squared
error over the ODB-only estimate. If, however, enrollment criteria bias the RCT
(i.e. the treatment effect varies by subpopulation and the RCT covariate distri-
bution differs substantively from that of the ODB), then the spiked-in estimator
can be much worse than the ODB-only estimate. In either case, the dynamic
weighted estimator brings an improvement over the ODB-only estimate. Sec-
tion 5 introduces data from the Women’s Health Initiative (WHI). An overview
of the components of the WHI and the data collection process is provided in
Section 5, while the subsequent sections detail how a propensity model is fit
to the WHI observational component and a “gold standard” estimate of the
causal effect is derived. A variant of the spiked-in estimator is introduced in
Section 5.4. That variant refines propensity strata via a prognostic score, lead-
ing to a “dual spiked” estimator. All the estimators are compared via bootstrap
simulations in 5.5, and the dual spiked estimate is most accurate for the WHI
data. Section 6 summarizes our conclusions and an Appendix contains two of
the lengthier proofs.
2 Notation, assumptions and estimators
Some subjects belong to the randomized controlled trial (RCT) and others to
the observational database (ODB). We assume that no subject is in both data
sets. We write i ∈ R if subject i is in the RCT and i ∈ O otherwise. Subject
i has an outcome Yi ∈ R and some covariates that we encode in the vector
xi ∈ Rd. Subject i receives either the test condition or the control condition.
The condition of subject i is given by a treatment variable Wi ∈ {0, 1} where
Wi = 1 if subject i is in the test condition (and 0 otherwise). Some formulas
simplify when we can use parallel notation for both test and control settings.
Accordingly we introduce Wit = Wi and Wic = 1 −Wi. Other formulas look
better when focused on the test condition. For instance, letting pit = Pr(Wit =
1) and pic = Pr(Wic = 1), the expression pit(1−pit) is immediately recognizable
as a Bernoulli variance and is preferred to pitpic.
2.1 Model
We adopt the potential outcomes framework of Neyman and Rubin. See Rubin
(1974). Subject i has two potential outcomes, Yit and Yic, corresponding to test
and control conditions respectively. Then Yi = WitYit +WicYic. The potential
outcomes (Yit, Yic) are non-random and we will assume that they are bounded.
We work conditionally on the observed values of covariates and so xi are also
non-random.
4
Symbols Meaning
i, k, ωk Subject and stratum indices, stratum weights
O, R, Ok, Rk ODB and RCT subject sets and strata
xi, e(xi) Covariates and ODB propensities
Yit, Yic, Yi Test, control and observed responses
Wit, Wic, Wi Test, control and observed indicators. Wi ≡Wit
τok = τrk = τk Stratum treatment effects: ODB, RCT, merged
nok, nrk, nk Stratum sample sizes: ODB, RCT, merged
τˆok, τˆrk ODB and RCT estimates of τˆk
τˆsk, τˆwk, τˆdk Spiked, weighted, dynamic estimates of τˆk
µokt, µokc Average potential responses by ODB stratum
µrkt, µrkc Average potential responses by RCT stratum
pokt, prkt Average propensities by ODB and RCT strata
prkc, prkc One minus average propensities
sokt, sokc Response-propensity covariances in the ODB
Table 1: Summary of notation used.
All of the randomness comes from the treatment variables Wi. We use
the notation Bern(p) for Bernoulli random variables taking the value 1 with
probability p and 0 with probability 1 − p. The ODB and RCT differ in how
the Wi are distributed.
Assumption 1 (ODB sampling). If i ∈ O, then Wi ∼ Bern(pi) independently
where pi = e(xi) with 0 < pi < 1.
The function e(·) in Assumption 1 is a propensity. Because the propensity
depends only on x, and is never 0 or 1, the ODB has a strongly ignorable
treatment assignment (Rosenbaum and Rubin, 1984). Because the Wi are in-
dependent, the outcome for subject i is unaffected by the treatment Wi′ for
any subject i′ 6= i. That is, our model for the ODB satisfies the stable unit
treatment value assumption or SUTVA (Imbens and Rubin, 2015).
Assumption 2 (RCT sampling). If i ∈ R, then Wi ∼ Bern(pr) independently
for a common probability 0 < pr < 1.
The RCT will commonly have pr = 1/2 but we do not assume this. Our RCT
model also has a strongly ignorable treatment assignment and it too satisfies
the SUTVA. We additionally assume that the ODB is independent of the RCT.
2.2 Stratification
Our comparison of treatment versus control is based on stratification by propen-
sity as described by Imbens and Rubin (2015). This is one of several matching
strategies mentioned in Stuart and Rubin (2007).
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We use K strata defined by propensity intervals. For the ODB these are
Ok =
{
i ∈ O ∣∣ k − 1
K
< e(xi) 6
k
K
}
, k = 1, . . . ,K.
The RCT is similarly stratified via
Rk =
{
i ∈ R ∣∣ k − 1
K
< e(xi) 6
k
K
}
, k = 1, . . . ,K.
Note that the RCT is stratified according to the propensity that those obser-
vations would have had, had they been in the ODB. Imbens and Rubin (2015)
suggest strata containing approximately equal numbers of observations. We
have instead given them equal sized propensity ranges. In practice, some small
strata might have to be merged together. Sometimes we refer to strata as ‘bins’.
We work here as though the propensity function e is known exactly. In prac-
tice, e will be replaced by an estimated propensity fit to the ODB. We suppose
that the ODB is large enough to obtain a good propensity estimate. Under
Assumption 1, the true propensity is a function of the observed variables xi.
The sample sizes of the ODB and RCT are no and nr respectively. Ordinarily
no  nr. The ODB and RCT sample sizes within stratum k are nok and nrk.
The within-stratum average treatment effects are
τok =
1
nok
∑
i∈Ok
Yit − Yic and τrk = 1
nrk
∑
i∈Rk
Yit − Yic, (1)
where means over empty strata are taken to be 0 in (1).
Assumption 3. For k = 1, . . . ,K, if nok > 0 and nrk > 0 then τok = τrk and
we call their common value τk.
Assumption 3 leaves τk undefined when min(nok, nrk) = 0. If only one of
nok and nrk is positive then we take its treatment effect for τk. If both are 0,
then we will not need τk.
Assumption 4. For all i ∈ Ok ∪Rk, Yit − Yic = τk.
Assumption 4 is an idealization that simplifies some derivations, and we
need it in one instance to estimate a quantity that depends on both potential
outcomes of a single subject. In some of our simulations we will relax that as-
sumption to make Yit − Yic constant for all units i at a fixed propensity score,
rather than within a stratum. Xie et al. (2012) have argued for analyzing the
pattern of treatment effects solely as a function of the propensity score, an ap-
proach taken by a number of social science researchers (Brand and Davis, 2011;
DellaPosta, 2013). Because our strata are based on propensity, Assumption 4
is very nearly true under the model of Xie et al. (2012).
Assumption 4 can be made more realistic by stratifying on both the propen-
sity score and a ‘prognostic score’ predicting the potential outcome for subjects
in the control group. We do this in Section 5.4 in the context of the WHI data.
6
2.3 Estimators
Our estimand is a global average treatment effect defined by
τ =
K∑
k=1
ωkτk
for weights ωk > 0 with
∑K
k=1 ωk = 1. The weights can be chosen to match pop-
ulation characteristics. Our choice is to take ωk = nok/no which is reasonable
when the ODB represents the target population of interest. With this choice,
ωk = 0 whenever nok = 0 and we have a well defined τk for every stratum that
contributes to τ . We may still have nrk = 0 for some strata with ωk > 0.
We now introduce some estimators designed to make use of the advantages
of both the RCT and the ODB data. Our estimators all take the form
∑
k ωk τˆk
for different within-stratum estimates τˆk.
Our two simplest proposed estimators each use just one of the two popula-
tions. The ODB-only estimate of the treatment effect in stratum k is
τˆok =
∑
i∈Ok WitYit∑
i∈Ok Wit
−
∑
i∈Ok WicYic∑
i∈Ok Wic
. (2)
Then τˆo =
∑
k ωk τˆok. A potential problem with τˆo is that small values of k,
corresponding to the left-most bins, have subjects with small propensity values.
Then Ok may contain very few observations with Wit = 1 and τˆok may have
high variance. Similarly for large k, Ok may contain very few observations with
Wic = 1 which again leads to high variance. That is, the ‘edge bins’ can have
very skewed sample sizes causing problems for τˆo.
The ODB estimate (2) is a difference of ratio estimators, because the de-
nominators are random. We will see in Section 3 that there can also be a severe
bias in the edge bins.
An analogous RCT-only estimator is τˆr =
∑
k ωk τˆrk where
τˆrk =
∑
i∈Rk WitYit∑
i∈Rk Wit
−
∑
i∈Rk WicYic∑
i∈RWic
. (3)
Because the RCT assigns treatments with constant probability, the edge bins
have less skewed treatment outcomes. However, because the RCT is small, we
may find that several of the strata have very small sample sizes nrk.
Our first hybrid estimator is τˆs =
∑
k ωk τˆsk, where
τˆsk =
∑
i∈Ok WitYit +
∑
i∈Rk WitYit∑
i∈Ok Wit +
∑
i∈Rk Wit
−
∑
i∈Ok WicYic +
∑
i∈Rk WicYic∑
i∈Ok Wic +
∑
i∈Rk Wic
. (4)
The RCT data are ‘spiked’ into the ODB strata. This spiked-in estimator can
improve upon the ODB estimator by increasing the number of treated units in
the low propensity edge bins and increasing the number of control units in the
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high propensity edge bins. Even a small number of such balancing observations
can be extremely valuable.
The spiked-in estimator is not a convex combination of τˆok and τˆrk, be-
cause the pooling is first done among the test and control units. Our final two
estimators are constructed as convex combinations of τˆok and τˆrk.
The weighted average estimator τˆw uses
τˆwk = λk τˆok + (1− λk)τˆrk, where λk = nok
nok + nrk
. (5)
It weights τˆrk and τˆok according to the number of data points involved in each
estimate.
Our final estimator is a “dynamic weighted average” τˆd. It uses weights
for τˆrk and τˆok that are estimated from the data. Those weights are chosen
to minimize an estimate of mean squared error (MSE) derived using the delta
method in the following section. While the precise form of this estimator will
be discussed next, we can observe its approximate optimality via the following
result, recalling that the RCT estimator will in general be unbiased.
Proposition 1. Let φˆ1 and φˆ2 be independent estimators of a common quan-
tity φ, with bias, variance and mean squared errors, Bias(φˆ1) ∈ (−∞,∞),
Bias(φˆ2) = 0, var(φˆj) and MSE(φˆj) ∈ (0,∞) for j = 1, 2. For c ∈ R, let
φˆc = cφˆ1 + (1− c)φˆ2. Then
c∗ ≡ argmin
c
MSE(φˆc) =
var(φˆ2)
MSE(φˆ1) + var(φˆ2)
.
This linear combination has
Bias(φˆc∗) =
Bias(φˆ1)MSE(φˆ2)
MSE(φˆ1) + MSE(φˆ2)
,
var(φˆc∗) = c
2
∗var(φˆ1) + (1− c∗)2var(φˆ2), and
MSE(φˆc∗) =
MSE(φˆ1)var(φˆ2)
MSE(φˆ1) + var(φˆ2)
.
(6)
Proof. Independence of the φˆj yields var(φˆc) = c
2var(φˆ1)+(1−c)2var(φˆ2) while
linearity of expectation yields Bias(φˆc) = cBias(θˆ1). Optimizing MSE(φˆc) over
c yields the result.
3 Delta method results
In this section we develop some delta method moment approximations. Let X
be a random vector with mean µ and a finite covariance matrix. Let f be a
function of X that is twice differentiable in an open set containing µ and let f1
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and f2 be first and second order Taylor approximations to f around µ. Then
the delta method mean and variance of f(X) are
Eδ(f(X)) = E(f2(X)) and varδ(f(X)) = var(f1(X))
respectively.
Sometimes, to combine estimates, we will need a delta method mean for a
weighted sum of those estimates. We will also need a delta method variance for
a weighted sum of independent random variables. We use the following natural
expressions
Eδ
(∑
j
λj τˆj
)
=
∑
j
λjEδ(τˆj) (7)
varδ
(∑
j
λj τˆj
)
=
∑
j
λ2jvarδ(τˆj), for independent τˆj (8)
without making recourse to Taylor approximations.
3.1 Population quantities
We will study our estimators in terms of some population quantities. These
involve some unobserved values of Yit or Yic. For instance, the test and control
stratum averages in the ODB are
µokt =
∑
i∈Ok Yit
nok
and µokc =
∑
i∈Ok Yic
nok
and it is typical that both of these are unobserved. Corresponding values for
the RCT are µrkt and µrkc.
When we merge ODB and RCT strata we will have to consider a kind of
skew in which the within-stratum mean responses above differ between the two
data sets. To this end, define
∆kt = µokt − µrkt and ∆kc = µokc − µrkc.
Under Assumption 3, ∆kt = (τk + µokc) − (τk + µrkc) = ∆kc. We will use
∆k = ∆kt = ∆kc.
Now we define several other population quantities. Let S be a finite non-
empty set of n = n(S) indices such as one of our strata Ok or Rk. For each
i ∈ S, let (Yit, Yic) ∈ [−B,B]2 be a pair of bounded potential outcomes and let
Wi = Wit be independent Bern(pi) random variables and let Wic = 1 −Wit.
Some of our results add the condition that all pi ∈ [, 1− ] for some  > 0.
For S so equipped, we define average responses
µt = µt(S) = 1
n
∑
i∈S
Yit and µc = µc(S) = 1
n
∑
i∈S
Yic. (9)
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For example, µokt above is µt(Ok). We use average treatment probabilities
pt = pt(S) = 1
n
∑
i∈S
pi and pc = pc(S) = 1− pt(S). (10)
These become pokt, pokc, prkt and prkc in a natural notation when S is Ok orRk.
The above quantities are averages over i uniformly distributed in S as dis-
tinct from expectations with respect to random Wi. We also need some covari-
ances of this type between response and propensity values,
st = st(S) = 1
n
∑
i∈S
Yitpi − µtpt and
sc = sc(S) = 1
n
∑
i∈S
Yic(1− pi)− µcpc.
(11)
We will find that these quantities play an important role in bias. If for instance
the larger values of Yit tend to co-occur with higher propensities pi then averages
are biased up.
The delta method variances of our estimators depend on the following weighted
averages of squares and cross products
Stt = Stt(S) = 1
n
∑
i∈S
pi(1− pi)(Yit − ρt)2,
Scc = Scc(S) = 1
n
∑
i∈S
pi(1− pi)(Yic − ρc)2, and
Stc = Stc(S) = 1
n
∑
i∈S
pi(1− pi)(Yit − ρt)(Yic − ρc),
(12)
where ρt = ρt(S) = µt(S) + st(S)/pt(S) and ρc = ρc(S) = µc(S) + sc(S)/pc(S).
The quantity ρt is the lead term in Eδ(
∑
i∈SWitYit/
∑
i∈SWit) and ρc is similar.
More details about these quantities are in the Appendix where Theorem 1 is
proved.
Proposition 2. Let S be Ok, Rk or Ok ∪ Rk. Then under Assumption 4,
sc(S) = −st(S).
Proof. Under Assumption 4, we can set Yit = Yic + τk and µt = µc + τk in (11).
3.2 Main theorem
We will compare the efficiency of our five estimators using their delta method
approximations. We state two elementary propositions without proof and then
give our main theorem. Results for our various estimators are mostly direct
corollaries of that theorem.
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Proposition 3. Let x and y be jointly distributed random variables with means
x0 6= 0 and y0 respectively, and finite variances. Let ρ = y0/x0. Then
Eδ
(y
x
)
= ρ− cov(y − ρx, x)
x20
, and (13)
varδ
(y
x
)
=
var(y − ρx)
x20
. (14)
Proposition 4. Let xt, xc, yt, yc be jointly distributed random variables with
finite variances and means xj,0 6= 0 and yj,0 respectively, for j ∈ {t, c}. Let
ρj = yj,0/xj,0. Then
varδ
( yt
xt
± yc
xc
)
=
var(yt − ρtxt)
x2t,0
+
var(yc − ρcxc)
x2c,0
± 2cov(yt − ρtxt, yc − ρcxc)
xt,0xc,0
.
Theorem 1. Let S be an index set of finite cardinality n > 0. For i ∈ S, let
Wit ∼ Bern(pi) be independent with 0 < pi < 1 and set Wic = 1−Wit. Let
τˆ =
∑
i∈SWitYit∑
i∈SWit
−
∑
i∈SWicYic∑
i∈SWic
where (Yit, Yic) ∈ [−B,B]2, for B < ∞. Then with µt, µc, pt, pc, st, sc, Stt,
Scc, Stc defined at equations (10) through (12),
varδ(τˆ) =
1
n
(
Stt
p2t
+
Scc
p2c
+ 2
Stc
ptpc
)
. (15)
If all pi ∈ [, 1− ] for some  > 0, then
Eδ (τˆ) = (µt − µc) +
(st
pt
− sc
pc
)
+O
( 1
n
)
. (16)
Proof. See Section 6.
The implied constant in O(1/n) for equation (16) holds for all n > 1.
3.3 Delta method means and variances
We define the delta method bias of an estimate τˆk via Biasδ(τˆk) = Eδ(τˆk)− τk.
Corollary 1. Let τˆok be the ODB-only estimator from (2). Then
varδ(τˆok) =
1
nok
(
Stt
p2t
+
Scc
p2c
+ 2
Stc
ptpc
)
,
where st, sc, pt, pc, Stt, Scc and Scc are given in equations (9) through (12)
with S = Ok. If 1 < k < K, then
Biasδ (τˆok) =
st
pt
− sc
pc
+O
(
1
nok
)
.
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If also Assumption 4 holds, then
Biasδ (τˆok) =
st
pt(1− pt) +O
(
1
nok
)
.
Proof. For 1 < k < K we can apply Theorem 1 with  = 1/K. Under
Assumption 4, sc = −st, so the lead term in Eδ(τˆk) is st(1/pt + 1/pc) =
st(pt + pc)/pt(1− pt) = st/pt(1− pt).
Corollary 2. Let τˆrk be the RCT-only estimator from (3). Then
Biasδ(τˆrk) = O
( 1
nrk
)
,
and
varδ(τˆrk) =
σ¯2rk
nrkpr(1− pr) , where
σ¯2rk =
1
nrk
∑
i∈Rk
[(Yit − µrkt)(1− pr) + (Yic − µrkc)pr]2,
(17)
for µrkt = µt(Rk) and µrkc = µc(Rk). Under Assumption 4, σ¯2rk = σ2rkt ≡
(1/nrk)
∑
i∈Rk(Yit − µrkt)2. If pr = 1/2, then
varδ(τˆrk) =
1
4n2k
∑
i∈Rk
(
Y¯i − µrkt + µrkc
2
)2
for Y¯i = (Yit + Yic)/2.
Proof. See Section 6.
The RCT has a very tiny delta method bias which arises purely from the
ratio estimator (random denominator) form of τˆrk. Conditional on there being
at least one treated and one control subject in the stratum, it can be shown that
τˆrk is exactly unbiased rather than just asymptotically unbiased. This follows
from symmetry: at every value of nrkt ∈ {1, 2, . . . , nrk − 1}, the estimator is
drawn uniformly at random from all permutations of the labels of who is treated
and who is not, and unbiasedness follows.
Corollary 3. Let τˆwk be the weighted-average estimator (5). Then, with λk =
nok/(nok + nrk),
varδ(τˆwk) =
λk
nok + nrk
(
Stt
p2t
+
Scc
p2c
+ 2
Stc
ptpc
)
+
1− λk
nok + nrk
σ¯2rk
pr(1− pr) ,
where Stt, Scc and Scc are given in equation (12) with S = Ok, and σ¯2rk is
defined at (17). If 1 < k < K, then
Biasδ(τˆwk) = λk
(
sokt
pokt
− sokc
pokc
)
+O
(
1
nok + nrk
)
,
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where sokt, pokt, sokc and pokc are defined by equations (10) and (11) for S =
Ok. If Assumption 4 also holds, then
Biasδ(τˆwk) =
λksokt
pokt(1− pokt) +O
(
1
nok + nrk
)
.
Proof. Using (7) and Corollaries 1 and 2, Biasδ(τˆwk) = λk × Biasδ(τˆok) for λk
given in (5). This yields the lead terms in both expressions for Biasδ(τˆwk). The
error terms are λkO(1/nok) = O(1/(nok + nrk)). Using independence of the
RCT and ODB, Corollaries 1 and 2, and definition (8)
varδ(τˆwk) =
λ2k
nok
(
Stt
p2t
+
Scc
p2c
+ 2
Stc
ptpc
)
+ (1− λk)2 σ¯
2
rk
nrkpr(1− pr)
=
λk
nok + nrk
(
Stt
p2t
+
Scc
p2c
+ 2
Stc
ptpc
)
+
1− λk
nok + nrk
σ¯2rk
pr(1− pr) .
In our motivating scenarios we anticipate that no  nr so that λk ≈ 1 for
most k. Then the first term in varδ(τˆwk) is only slightly smaller than varδ(τˆok)
for the ODB-only estimate, and at most a small variance reduction is to be
expected from weighting.
The spiked-in estimator’s bias and variance cannot be computed as a corol-
lary of Theorem 1, but they can be computed directly.
Corollary 4. Let τˆsk be the spiked-in estimator (5). Then
varδ(τˆsk) =
1
nok + nrk
(
Stt
p2t
+
Scc
p2c
+ 2
Stc
ptpc
)
,
where st, sc, pt, pc, Stt, Scc and Stc are given in equations (9) through (12)
with S = Ok ∪Rk. If 1 < k < K, then
Biasδ (τˆsk) =
st
pt
− sc
pc
+O
(
1
nok + nrk
)
.
If Assumption 4 also holds, then
Biasδ (τˆsk) =
st
pt(1− pt) +O
(
1
nok + nrk
)
.
Proof. The spike-in estimates are computed by pooling Ok and Rk into their
union.
The edge bins are not covered by Corollary 4. Inspection of the proof of
Theorem 1 shows that the bias error term is O((nok + nrk)/n
2
rk). No such
bound is available for τˆok or τˆwk for edge bins.
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To relate the bias of τˆsk to that of the other estimators, we write it in terms of
the quantities computed using S = Ok and S = Rk. Denoting these quantities
using an additional subscript of o and r,
Biasδ (τˆsk) = ∆knok
(
pokt
nokpokt + nrkprkt
− pokc
nokpokc + nrkprkc
)
+
sokt
nok
nokpokt + nrkprkt
− sokc nok
nokpokc + nrkprkc
+O
(
1
nok + nrk
)
.
(18)
The bias for τˆrk is zero. The bias for τˆok has terms analogous to the second and
third (and error) terms above, but the first term is new to τˆsk. This term is
linear in ∆k. For large values of ∆k, this term will dominate, yielding biases that
can easily exceed those of τˆok. This is the fundamental danger of the spiked-in
estimator: if the mean potential outcomes differ substantially between ODB
and RCT subjects with similar value of the propensity score function, then the
estimation will be poor due to large bias.
3.4 The dynamic weighted estimator
The bias-variance tradeoffs are intrinsically different in each stratum. Using
results from the prior section, we derive a dynamic weighted estimator that uses
different weights in each stratum. Our dynamic weighted estimator is based on
Assumption 4, though we will test it in settings where that assumption does
not hold.
From Proposition 1, the MSE-optimal convex combination of τˆok and τˆrk is
c∗k τˆok + (1− c∗k)τˆrk where c∗k = var(τˆrk)/(var(τˆrk) + MSE(τˆok)). The dynamic
weighted estimator is
τˆdk = cˆ∗k τˆok + (1− cˆ∗k)τˆrk, with cˆ∗k = v̂ar(τˆrk)
v̂ar(τˆrk) + M̂SE(τˆok)
, (19)
for plug-in estimators of MSE(τˆok) and var(τˆrk). To obtain our MSE estimates
we use M˜SE(·) = Biasδ(·)2 + varδ(·) taking the delta method moments from
Corollaries 1 and 2. These expressions include some unknown population quan-
tities that we then approximate from the data to get M̂SE(·).
For the ODB estimate we use
M˜SE(τˆok) =
(
st
pt(1− pt)
)2
+
1
nok
(
Stt
p2t
+
Scc
p2c
+ 2
Stc
ptpc
)
where the quantities on the right hand side are given in Section 3.1 with S = Ok.
For the RCT estimate we use
v˜ar(τˆrk) =
σ¯2rk
pr(1− pr)nrk , with σ¯
2
rk =
1
nrk
∑
i∈Rk
Witσˆ
2
rkt +Wicσˆ
2
rkc
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where σˆ2rkt, σˆ
2
rkc are the sample variances observed among the treated and con-
trol units respectively. Both of these estimates use Assumption 4.
The values of pt and pc are known: pt =
∑
i∈Ok pit/nok where pit is the
propensity e(xi) and pc = 1 − pt. We use Horvitz-Thompson style inverse
probability weighting to estimate other quantities, as follows:
ρˆt =
∑
i∈Ok WitYit∑
i∈Ok Wit
, ρˆc =
∑
i∈Ok WicYic∑
i∈Ok Wic
,
sˆt =
∑
i∈Ok Wit
nok
(∑
i∈Ok
WitYit − pt
∑
i∈Ok
WitYit/pit
)
+
∑
i∈Ok Wic
nok
(∑
i∈Ok
WicYic − pc
∑
i∈Ok
WicYic/pic
)
,
Sˆtt =
∑
i∈Ok Witpit(1− pit)(Yit − ρˆt)2∑
i∈Ok Wit
, and
Sˆcc =
∑
i∈Ok Wicpit(1− pit)(Yic − ρˆc)2∑
i∈Ok Wic
.
The sole quantity that does not have a Horvitz-Thompson estimator is
Stc(Ok), because we never observe both potential outcomes for a given unit.
First, we write Stc as
1
n
∑
i∈Ok
Witpit(1− pit)(Yit − ρt)(Yic − ρc) + 1
n
∑
i∈Ok
Wicpit(1− pit)(Yit − ρt)(Yic − ρc).
Next, under Assumption 4,
Yit − ρt = Yic + τk − µt − st/pt = Yic − ρc − st
ptpc
,
and similarly Yic − ρc = Yit − ρt + st/(ptpc). Therefore
Stc =
1
n
∑
i∈Ok
Witpit(1− pit)(Yit − ρt)2 + 1
n
∑
i∈Ok
Wicpit(1− pit)(Yic − ρc)2−
− st
npt(1− pt)
(∑
i∈Ok
Witpit(1− pit)(Yit − ρt)−Wicpit(1− pit)(Yic − ρc)
)
(20)
and we get Sˆtc by plugging the above estimates of ρt, ρc and known values of
pt, pc into (20). Although Assumption 4 is used to derive the estimator, some
of our simulations in Section 4 test it under a violation of that assumption.
3.5 Performance comparison
The ideal dynamic estimator with the optimal weight ck∗ must be at least as
good as τˆok, τˆrk and τˆwk because those estimators are all special cases of weight-
ing estimators belonging to the class that ck∗ optimizes over. Our estimator τˆdk
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will not always be better than those other estimators, because it uses an estimate
cˆk∗ which could introduce enough error to make it less efficient.
When combining stratum-based estimates τˆk into the weighted estimator
τˆ =
∑
k ωk τˆk, there is the possibility of biases canceling between strata. None of
the competing estimators we consider are designed to exploit such cancellation.
For large strata, ck∗ should be well estimated. To arrange cancellations among
biased within-stratum estimates would require domain-specific assumptions that
we do not make here.
The comparison to the spiked-in estimator is more complex. As we saw
in equation (18), the bias can grow without bound in ∆k, so for large ∆k this
estimator will have the largest MSE. However, for small values of ∆k, the spiked-
in estimator can outperform all the other estimators. To see why, we make a
direct comparison with the dynamic weighted estimator and reference our prior
discussion showing the dynamic weighted estimator will generally outperform
τˆok, τˆrk and τˆwk.
We introduce sample counterparts of ∆k, given by
∆ˆkt =
∑
i∈Ok WitYit∑
i∈Ok Wit
−
∑
i∈Rk WitYit∑
i∈Rk Wit
, and
∆ˆkc =
∑
i∈Ok WicYic∑
i∈Ok Wic
−
∑
i∈Rk WicYic∑
i∈Rk Wic
.
Then after some algebra τˆsk differs from the RCT estimate as follows,
τˆsk − τˆrk = ckt∆ˆkt − ckc∆ˆkc (21)
for sample size proportions
ckt =
∑
i∈Ok Wit∑
i∈Ok∪Rk Wit
and ckc =
∑
i∈Ok Wic∑
i∈Ok∪Rk Wic
.
By comparison,
τˆdk − τˆrk = ck?∆ˆkt − ck?∆ˆkc, (22)
where the dynamic estimator tunes ck? to the available data. An oracle could
choose ck? optimally using Proposition 1. While the oracle is working in a one
parameter family (22) for each bin k, the spiked-in estimator uses two weights ckt
and ckc (21) that are not necessarily within the family that the oracle optimizes
over. This is why it is possible for the spiked estimator to outperform the oracle.
4 Simulations
Our goal is to estimate the average treatment effect in the target population,
from which we assume the ODB data was randomly sampled. The value of the
RCT is that it can substitute for ODB data in places where that data is sparse
due to the treatment assignment mechanism.
16
We simulate two high level scenarios. In one, the RCT is a random sample
from the same population that the ODB came from. Then the RCT and ODB
data differ only in their treatment assignment mechanisms. We consider this
case the ideal one for our approach of merging the RCT into the ODB. In the
other scenario, the RCT is subject to some potentially biasing inclusion criteria
on the explanatory variables xi. Such biases are a frequent concern for RCTs
(Susukida et al., 2016; Stuart and Rhodes, 2017).
For both of these high level scenarios, we vary the treatment effect over
strata, making it either constant, linear or quadratic in k = 1, . . . ,K. Section 4.1
shows results for our ideal case where xi have the same distribution in both
data sets and Assumption 4 holds. Section 4.2 models a sampling bias for
the xi values in the RCT while retaining Assumption 4. Section 4.3 removes
Assumption 4 from both of the prior simulation settings.
4.1 Simulation of the ideal case
We begin with the simulations satisfying Assumption 4, with the RCT sampled
from the same distribution as the ODB. This is an ideal case. First we describe
how the ODB data are generated, then the RCT data.
In all of our simulations xi ∈ R5. The ODB has no = 5,000 subjects. On
each new sampling of the covariates, we first sample a covariance matrix Σ ∈ R5,
such that each covariate has unit variance, and covariances are randomly 0 with
1/2 probability, and ±0.1 with 1/4 probability. Such a covariance structure is,
on average, roughly consistent with the covariance structure in the real dataset
in Section 5. We then generate xi
iid∼ N (0,Σ) for i ∈ O and we assume that for
the control condition:
Yic = x
T
i β + εi, for β = (1, 1, 1, 1, 1)
T
where εi are generated as IID N (0, 1) random variables. We assume that the
user does not know the precise form of the generative model and uses the strat-
ified estimates we presented above.
The treatment variables in the ODB are independent Bernoulli random vari-
ables with
Pr(Wi = 1) =
1
1 + e−γTxi
.
We consider the four γ vectors given in Table 2. Two of them are orthogo-
nal to β. The others are correlated with β and will result in the test group
having higher average responses in the ODB than the control group. For each
correlation pattern we have two sizes of ‖γ‖.
The treatment values Yit are equal to Yic plus a treatment effect that obeys
Assumption 4. We use three structures. In all cases Yit = Yic + τk for i ∈ Ok.
The values of τk in constant, linear and quadratic treatment effect models are
τk = T, τk = T × k
K
, and τk = T ×
( k
K
− 1
2
)2
(23)
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γ:

1
1
1
0
0


√
2√
2√
2
0
0


√
3/2
−√3/2√
3/2
−√3/2
0


√
6/2
−√6/2√
6/2
−√6/2
0

γTβ: 3 3
√
2 0 0
‖γ‖2: 3 6 3 6
Table 2: These are the four γ vectors used in our simulations. The first two
correlate with the mean response vector β, while the second two do not. The
second and fourth imply larger sampling biases than the first and third do.
respectively. In each case we choose the scale T > 0 so that Cohen’s d (Cohen,
1988) in the ODB precisely equals 0.5, which Cohen calls a medium effect size.
The value of T varies across simulations based on the simulation settings and
the randomness in the sampling of xi.
We turn now to the RCT. It has nr = 200 subjects in it. Their xi are
chosen from the same distribution as in the ODB (including the same covariance
matrix Σ), but now Wi
iid∼ Bern(1/2). The same constant, linear and quadratic
treatment effects from the ODB are used in the RCT.
We simulate the covariates xi and potential outcomes (Yit, Yic) for i ∈ O∪R
100 times. For each realization of the covariates and potential outcomes we make
20 independent simulations of the treatment variables Wi, for a total of 2,000
simulations. In all cases we choose K = 20 propensity bins where the k’th
one has e(xi) ∈ [(k − 1)/20, k/20) for k = 1, . . . ,K. This simulation satisfies
Assumptions 1 through 4.
In each simulation run, we estimate the average treatment effect using each
of our five estimators. We also estimate using an ‘oracle’ estimator, which
knows the true MSE of the ODB-only and RCT-only estimators in each stratum
and thus the optimal weighting between these estimators. The MSE of the
estimators are computed across all 2,000 simulation runs,.
The results are shown in Table 3. In this ideal setting, the spike-in estimator
always has the lowest MSE. It was always superior to the better of the RCT
and ODB estimators. Even though the RCT only adds 200 subjects to the
5,000 in the ODB, it leads to a spiked-in estimator whose MSE ranges from
about 50% to about 80% of that of the ODB. As we discussed in Section 3.5,
this setting has ∆k = 0 and the RCT and ODB points have similar variances
conditionally on the propensity score. It even outperforms the oracle estimator
which optimizes the relative weights on the RCT and ODB within strata. The
spiked-in estimator can beat the oracle because it is not one of the weighting
schemes over which the oracle has optimized. The oracle is the second-best
performer in each condition. The dynamic weighted estimator – which seeks
to recover the oracle weights – has an MSE only slightly inflated relative to
the oracle, with no performance gap larger than 15%. The dynamic weighted
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estimator also generally outperforms the weighted-average estimator.
Trt. Cor. ‖γ‖22 ODB RCT Wtd. Spike Dyn. Oracle
c y 3 0.0069 0.0776 0.0066 0.0053 0.0065 0.0058
c y 6 0.0222 0.0780 0.0207 0.0113 0.0134 0.0129
c n 3 0.0117 0.1522 0.0110 0.0091 0.0110 0.0099
c n 6 0.0209 0.1457 0.0198 0.0138 0.0182 0.0163
l y 3 0.0076 0.0761 0.0071 0.0056 0.0066 0.0060
l y 6 0.0220 0.0787 0.0204 0.0111 0.0132 0.0128
l n 3 0.0122 0.1574 0.0116 0.0094 0.0118 0.0104
l n 6 0.0219 0.1434 0.0204 0.0137 0.0177 0.0160
q y 3 0.0077 0.0766 0.0072 0.0054 0.0066 0.0060
q y 6 0.0236 0.0791 0.0220 0.0113 0.0143 0.0139
q n 3 0.0122 0.1536 0.0115 0.0096 0.0116 0.0103
q n 6 0.0202 0.1414 0.0189 0.0124 0.0167 0.0152
Table 3: MSEs for treatment effect in the ideal setting. Column 1 gives
treatment (constant, linear, quadratic). Column 2 shows whether the propensity
was correlated with the mean response. Column 3 indicates the magnitude of
the propensity vector γ. The remaining columns are mean squared errors for
the overall treatment from our 5 estimators and an oracle. In every case, the
spiked-in estimator using (4) has lowest MSE.
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Estimator Performance: Quadratic Treatment Effect, Ideal Case
Figure 1: Performance measures across all 2,000 simulations run in the ideal
case. Bias squared is shown in black, and variance in gray, so that total bar
height represents the MSE. The much larger values for the RCT estimator are
excluded to make visual comparison easier.
The outcomes in Table 3 are quite consistent. Nine out of 12 settings have the
same ordering. From best to worst they are: spiked, oracle, dynamic, weighted,
ODB and RCT. In two of the cases (rows 3, 7, and 11) the weighted method
very slightly outperforms the dynamic method.
Inspection of the data in Table 3 shows that the RCT-only estimate is far
from competitive. This is not surprising as that estimate uses much less data
than the other methods. To make comparison easier, we exclude the RCT
estimator from our graphical presentation in Figure 1. Bias squared is shown
in black, and variance in gray, so that total bar height represents the MSE.
The treatment effect patterns make very little difference, so we show only the
case of the quadratic treatment effect. These results show that the advantage
of the spiked-in estimator is greatest when ‖γ‖ is large. In this case, the benefit
mostly accrues due to a reduced variance for the spiked-in estimator relative to
the dynamic estimator.
4.2 Restrictive enrollment criteria
It is common for an RCT to have enrollment criteria such that the values of
xi in it are different from those in the general population. The RCT might be
designed to avoid frail patients. Or it might be designed to include patients with
the worst prognoses, who are most in need of a novel treatment. We illustrate
restrictive enrollment by having the RCT sample xi from N (0,Σ) subject to
20
Trt. Cor. ‖γ‖22 ODB RCT Wtd. Spike Dyn. Oracle
c y 3 0.0075 0.1505 0.0068 0.0119 0.0060 0.0056
c y 6 0.0222 0.1681 0.0200 0.0186 0.0129 0.0121
c n 3 0.0114 0.1623 0.0106 0.0320 0.0104 0.0093
c n 6 0.0212 0.1965 0.0192 0.0667 0.0158 0.0140
l y 3 0.0074 0.4137 0.0068 0.0129 0.0062 0.0058
l y 6 0.0226 0.4918 0.0203 0.0191 0.0132 0.0123
l n 3 0.0124 0.2578 0.0115 0.0358 0.0109 0.0098
l n 6 0.0207 0.3015 0.0189 0.0627 0.0161 0.0141
q y 3 0.0075 0.3854 0.0069 0.0119 0.0062 0.0057
q y 6 0.0222 0.2886 0.0201 0.0186 0.0131 0.0124
q n 3 0.0126 0.2984 0.0116 0.0356 0.0109 0.0101
q n 6 0.0214 0.2569 0.0196 0.0684 0.0169 0.0150
Table 4: MSEs for treatment effect in the setting with restricted enrollments.
The columns are the same as in Table 3. Here the oracle estimator is always
best and the dynamic estimator is the best of the ones that can be implemented.
both xi1 < −1 and xi5 < −1. Because our β vector has all positive entries, these
restrictions mean that subjects in the RCT tend to have smaller values of Yic
than those in the ODB. Smaller could either mean better or worse depending on
what quantity Y measures. The first restriction is on a variable that influences
the propensity for treatment in the ODB, while the second restriction is on a
variable that does not influence this propensity.
The results under this restriction are presented in Table 4. Nine of the 12
settings have the same ordering. From best to worst they are: oracle, dynamic,
weighted, ODB, spiked, and RCT. In the remaining three cases, the spiked
estimator is third, the weighted estimator fourth, and the ODB estimator fifth,
with the other rankings unchanged. Across all settings, the best usable method
is the dynamic one. The dynamic MSE was never more than 15% higher than
that of the oracle that it seeks to approximate. Sometimes it was up to 40%
more efficient than the ODB-only estimator.
The bad performance of the spiked-in estimator here is attributable to the
restriction on the fifth component of xi. That restriction affects the outcomes
(Yic, Yit) but not the propensity score because γ5 = 0. The result is a large
∆k in each stratum, making the spiked-in estimator perform much worse than
in the prior scenario. This effect can be seen in Figure 2, where the spiked-in
estimator consistently demonstrates a large squared bias, resulting in a high
MSE.
4.3 Violation of Assumption 4
In this section we simulate in a setting where Assumption 4 fails to hold but
Assumption 3 does hold. We modify the linear and quadratic treatment effects
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Estimator Performance: Quadratic Treatment Effect, Restricted
Enrollment Case
Figure 2: Performance measures across all 2,000 simulations run in the re-
stricted enrollment case. Bias squared is shown in black, and variance in gray,
so that total bar height represents the MSE. The much larger values for the
RCT estimator are excluded to make visual comparison easier.
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Trt. Cor. ‖γ‖22 ODB RCT Wtd. Spike Dyn. Oracle
l y 3 0.0077 0.0812 0.0073 0.0055 0.0068 0.0061
l y 6 0.0243 0.0787 0.0226 0.0113 0.0148 0.0144
l n 3 0.0116 0.1456 0.0110 0.0091 0.0113 0.0100
l n 6 0.0210 0.1443 0.0197 0.0137 0.0178 0.0157
q y 3 0.0070 0.0806 0.0066 0.0050 0.0062 0.0056
q y 6 0.0191 0.0772 0.0177 0.0091 0.012 0.0117
q n 3 0.0122 0.152 0.0116 0.0092 0.0113 0.0102
q n 6 0.0209 0.1575 0.0195 0.0136 0.0179 0.0160
Table 5: These are the results of the simulations where Assumption 4 is violated
but the RCT has the same x distribution as the ODB.
in equation (23) to have
Yit − Yic = T × e(xi), and Yit − Yic = T × (e(xi)− 1/2)2
respectively. T is again selected so that Cohen’s d in the ODB is equal to 0.5.
The treatment difference now depends on the actual propensity of each subject
but it varies with the strata. We do not re-simulate the constant case because
it is the same either way.
If the RCT is sampled randomly from the population, we get the results in
Table 5. Here again, the rankings are very stable. Seven times out of 8, the
ranking from best to worst is: spiked, oracle, dynamic, weighted, ODB and RCT.
One time the weighted estimator slightly outperformed the dynamic estimator.
The orderings are essentially unchanged from the case when Assumption 4 held.
The value of ∆k here, while not zero, is not very large. The dynamic estimator
is still a good approximation to the oracle, with an MSE never more than 14%
larger.
Finally, we consider the setting where Assumption 4 is violated and the RCT
has the enrollment restrictions from Section 4.2. The results are in Table 6. In
6 of 8 cases, the ranking is: oracle, dynamic, weighted, ODB, spiked and RCT,
just as it predominantly was when Assumption 4 held. The two dissimilar
cases still have the oracle and dynamic estimators as the top performers. Taken
together, these results indicate that the dynamic weighted estimator is robust
to this type of weakening of Assumption 4.
Additional simulations were also conducted to explore the effect of the co-
variance structure between the covariates. Results were substantively similar
with both Σ = I5 – i.e., independent covariates – as well as with stronger corre-
lations among the covariates. Performance of the spiked-in estimator was seen
to degrade somewhat less with restrictive enrollment criteria when covariance
was high, and somewhat more in the independent case. These simulations are
omitted here for brevity.
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Trt. Cor. ‖γ‖22 ODB RCT Wtd. Spike Dyn. Oracle
l y 3 0.0077 0.4037 0.0071 0.0128 0.0064 0.0059
l y 6 0.0247 0.5027 0.0223 0.0186 0.0142 0.0133
l n 3 0.0127 0.2723 0.0117 0.0328 0.0111 0.0101
l n 6 0.0201 0.3293 0.0185 0.0657 0.0155 0.0142
q y 3 0.0068 0.2771 0.0063 0.0134 0.0058 0.0054
q y 6 0.0211 0.2451 0.0194 0.0173 0.0137 0.0130
q n 3 0.0126 0.2547 0.0116 0.0356 0.0108 0.0100
q n 6 0.0216 0.2137 0.0199 0.0683 0.0168 0.0152
Table 6: These are the results of the simulations where Assumption 4 is violated
and the x in the RCT are subject to restrictive enrollment criteria.
5 WHI data example
In this section we evaluate our estimators on data from the Women’s Health
Initiative (WHI) to estimate the effect of hormone therapy (HT) on coronary
heart disease (CHD). The WHI is a study of postmenopausal women in the
United States, consisting of randomized controlled trial and observational study
components with 161,808 total women enrolled (Prentice et al., 2005). Eligibility
and recruitment data for the WHI can be found in Hays et al. (2003) and Writing
Group for the Women’s Health Initiative Investigators (2002). Participants were
women between 50 and 79 years old at baseline, who had a predicted survival
of at least three years and were unlikely to leave their current geographic area
for three years.
Women with a uterus who met various safety, adherence, and retention cri-
teria were eligible for a combined hormone therapy trial. A total of 16,608
women were randomized to the treatment arm, 8,506 women of whom were
were assigned to take 625 mg of estrogen, and 2.5 mg of progestin, and the
remainder of whom received a placebo. A corresponding 53,054 women in the
observational component of the WHI had an intact uterus and were not using
unopposed estrogen at baseline, thus rendering them comparable according to
Prentice et al. (2005) . About a third of these women were using estrogen plus
progestin, while the remaining women in the observational study were not using
hormone therapy (Prentice et al., 2005).
Participants received semiannual contacts and annual in-clinic visits for the
collection of information about outcomes. Disease events, including CHD, were
first self-reported and later adjudicated by physicians. We focus on outcomes
during the initial phase of the study, which extended for an average of 8.16 years
of follow-up in the RCT and 7.96 years in the ODB.
The overall rate of CHD in the trial was 3.7% in the treated group (314
cases among 8,472 women) versus 3.3% (269 cases among 8,065 women) among
women not randomized to estrogen and progestin. In the observational study,
the corresponding rates were 1.6% among treated women (706 out of 17,457
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women) and 3.1% among control women (1,108 out of 35,408 women). Our
methodology compares means and not survival curves. In the initial follow-up
period, death rates were relatively low in both the ODB (6.4%) and the RCT
(5.7%). Hence, we do not make corrections for the possibility of these deaths
censoring CHD events.
5.1 Covariate imbalance and modeling
The WHI researchers collected a rich set of covariates about the participants in
the study. For the purposes of computational speed, we narrow to a set of 684
variables, spanning demographics, medical history, diet, physical measurements,
and psychosocial data collected at baseline.
A crude measure of covariate imbalance can be found by looking at the dis-
tribution of p-values associated with each covariate. For continuous covariates,
the p-value is computed by regressing the treatment indicator on the covariate
and computing the p-value of the coefficient; for categorical covariates, it is
computed via an a χ2 table test.
If the selection into the treated and control groups is dependent on the
covariates, then we would expect a p-value distribution highly skewed towards
0. If the selection is independent of the covariates (as we expect for an RCT),
the p-value distribution should be approximately uniform. This is precisely
what we see in Figure 3.
Figure 3: Imbalance p-value distribution across 684 covariates in the observa-
tional (OS) and estrogen and progestin randomized controlled trial (E+P RCT)
data.
A more meaningful measure of covariate imbalance can be found by looking
at clinically relevant factors. Prentice et al. (2005) identified factors that are
correlated with CHD. They found that HT users in the observational study
were more likely to be Caucasian or Asian/Pacific Islander, less likely to be
overweight, and more likely to have a college degree. These imbalances strongly
suggest that applying a naive differencing estimate to the observational data
will yield an unfairly rosy view of the effect of hormone therapy (HT) on CHD.
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To generate our estimators for this dataset, we need a propensity model
e(x) to map the observed covariates to an estimated probability of receiving the
treatment in the observational study. In constructing this model, we have two
potentially conflicting goals:
1) The model should fully account for the effect of covariates on the selection
into the treatment group in the observational study, and
2) the model should generalize to the RCT such that we an obtain an ac-
curate estimate of what probability of receiving HT would have been for
RCT participants had they not been randomized to treatment or control.
We do not need e(xi) to have a causal interpretation for the treatment. It only
needs to have a strong association with the assignment of subject i to the test
or control treatment.
To achieve these goals, we used a logistic regression-based procedure designed
to generate an expressive model while limiting overfit. We also explored more
complex models, such as random forests and generalized boosted trees, but
found little benefit along with a dramatic increase in runtime.
A forward stepping algorithm was first applied to the observational dataset
to put an ordering on the variables. All 684 baseline covariates were provided
as candidates to a logistic regression predicting the treatment indicator, and
variables were automatically added, one at a time, based on which addition
most reduced Akaike’s Information Criterion (Akaike, 1974).
Using this ordering, models containing from one to 120 variables were gener-
ated. Model fit was assessed via the area under the Receiver Operator Charac-
teristic curve, or ROC AUC. At each model size, the ROC AUC was computed
first for the nominal model and then computed again using a ten-fold cross-
validation. This procedure generated the curves seen in Figure 4. Notably, we
observe that the predictive power rises rapidly with the addition of the first
twenty variables to the logistic regression model, but slows dramatically there-
after. There is also very little evidence of overfit, as the nominal AUC only very
slightly outpaces the cross-validated AUC, even in models with 100 or more
variables. This is likely a consequence of the sheer number of observations in
the OS dataset.
We next applied a heuristic threshold, selecting the largest model such that
the most recent variable addition increased the cross-validated AUC by at least
one basis point (0.01%). This yields a model containing 53 variables, with
an ROC AUC of 82.49%, or about 1% lower than a model containing all 684
covariates. Our goal is to get an association between e(xi) and Wi. Additional
variables beyond the 53’rd do not materially improve this association, so we
omit them.
Matching on the propensity score should reduce imbalances on clinically rel-
evant covariates. To evaluate this effect, we use the standardized differences
approach of Rosenbaum (2009, Chapter 9). Let x¯tj and x¯cj be the treated and
control group averages for continuous covariate j in the ODB before matching
and let σˆ2tj and σˆ
2
cj be the sample variances within those two groups. Let x¯tjk and
x¯cjk be those averages taken over subjects i ∈ Ok and define post-stratification
averages as x˜tj =
∑
k nokx¯tjk/no and x˜cj =
∑
k nokx¯cjk/no. These are weighted
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Figure 4: Nominal and cross-validated receiver operator characteristic area
under curve for propensity models with different numbers of variables
averages of xij with greater weight put on observations from treatment condi-
tions that are underrepresented in their own strata. Rosenbaum’s standardized
differences for the original and reweighted data are
SDj =
x¯tj − x¯cj√
1
2 (σˆ
2
tj + σˆ
2
cj)
and S˜Dj =
x˜tj − x˜cj√
1
2 (σˆ
2
tj + σˆ
2
cj)
,
respectively. These quantities measure the practical significance of the imbal-
ance between groups unlike t-statistics which have a standard error in the de-
nominator. Note that Rosenbaum uses the same denominator in both weighted
and unweighted standardized differences.
We first tried ten equal-width propensity score strata to evaluate the stan-
dardized differences between treated and control on risk factors listed in Prentice
et al. (2005) before and after adjusting for the propensity score. With the ex-
ception of the physical functioning score, all of these covariates were included
in the propensity model. Imbalance measures for the continuous covariates can
be found in Table 7. As we can see, the stratification procedure reduces all
standardized differences to less than 0.05 in absolute value, representing very
good matches between the populations. As sufficient balance was achieved with
ten strata – and finer stratification would increase variance – we stuck with
ten propensity score strata for this analysis, rather than the twenty used in
simulation.
For categorical variables, the stratification procedure similarly reweights in-
dividual women, such that the effective proportion of women in each category
changes after stratifying on the propensity score. Standardized differences can
also be computed for categorical variables, using the procedure described in
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Graziano and Raulin (1993). We achieve similar balance on two significant
categorical variables – ethnicity and smoking status – in Tables 8 and 9.
Table 7: Standardized differences (SD) between treated and control populations
in the observational dataset, before and after stratification on the propensity
score, for clinical risk factors for coronary heart disease.
Unweighted Stratified
Test Ctrl SD Test Ctrl SD
Age 60.78 64.72 −0.56 63.06 63.33 −0.04
BMI 25.55 27.11 −0.25 26.71 26.62 0.00
Physical functioning 85.23 79.58 0.26 81.15 81.23 0.03
Age at menopause 50.49 50.19 0.06 50.35 50.33 0.02
Table 8: Standardized differences (SD) between treated and control populations
in the observational database, before and after stratification on the propensity
score, for ethnicity category.
White Black Latino AAPI
Native
American
Missing/
Other
SD
Before
Stratifying
Treated 89.0% 2.7% 2.9% 4.0% 0.2% 1.1%
0.26
Control 83.1% 8.1% 3.9% 2.8% 0.4% 1.5%
After
Stratifying
Treated 83.4% 6.9% 4.3% 3.6% 0.5% 1.4%
0.05
Control 84.8% 6.4% 3.6% 3.4% 0.4% 1.4%
Table 9: Standardized differences (SD) between treated and control populations
in the observational database, before and after stratification on the propensity
score, for smoking category.
Never
Smoked
Past
Smoker
Current
Smoker
SD
Before
Stratifying
Treated 48.7% 46.2% 5.1%
0.11
Control 52.3% 41.1% 6.6%
After
Stratifying
Treated 50.9% 42.5% 6.6%
0.01
Control 51.0% 42.7% 6.3%
5.2 Propensity score distribution
The propensity model can now be applied to the treated and control women in
both the observational and RCT populations. Among women in the observa-
tional study, the model prediction can be interpreted as the estimated probabil-
ity of receiving HT given a woman’s covariates. Among women in the RCT, the
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prediction can be interpreted as what that probability would have been had the
woman not been enrolled in the trial – or, simply, as a balancing score without
intrinsic meaning.
The distributions of these model predictions can be found in Figure 5. The
distribution of propensity scores is indeed quite different between the treated
and control populations in the observational data, with women who received HT
generally having higher propensity scores than women who did not. No such
discrepancy exists in the RCT, where randomization makes it unlikely that the
propensity score distribution differs between the treated and control women.
Also notable is the discrepancy between the marginal distributions. Overall,
women enrolled in the RCT tended to have a lower probability of receiving HT,
with virtually no women in the highest deciles of the propensity score.
Figure 5: Propensity score distributions among treated and control women
(left panel) and marginal propensity score distributions (right panel) for the
observational database (ODB) and randomized controlled trial (RCT) Women’s
Health Initiative populations.
5.3 Gold standard causal effect
We now turn our attention to estimation of the “gold standard” causal effect.
We randomly partition the RCT into two subsets of equal size, such that each
contains the same number of treated and control women. We select one of these
subsets and refer to it as our “gold” dataset, to be used for estimating the true
causal effect. The remaining subset is referred to as the “silver” dataset, and is
used for evaluating our estimators.
Because of the randomization, we find that treated and control are already
well balanced on the coronary heart disease risk factors in the gold dataset, as
summarized in Tables 10, 11, and 12.
We face two key question in estimating the gold standard causal effect:
against whom do we compare each of the treated units, and how do we reweight
the causal effects? We want to impose minimal assumptions on the data and also
make use of the wealth of prior research from WHI. Hence, for comparisons, we
take the approach of Prentice et al. (2005) and make treated-vs-control compar-
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Table 10: Standardized differences (SD) between treated and control popula-
tions in RCT gold dataset, for clinical risk factors for coronary heart disease.
Variable Treated Control SD
Age 63.24 63.41 −0.02
BMI 28.33 28.38 −0.01
Physical functioning 80.97 81.11 −0.01
Age at menopause 44.97 46.33 −0.09
Table 11: Standardized differences (SD) between treated and control popula-
tions in RCT gold dataset, for ethnicity category.
White Black Latino AAPI
Native
American
Missing/
Other
SD
Treated 84.1% 6.5% 5.5% 2.1% 0.26% 1.6%
0.05
Control 84.6% 6.8% 5.1% 1.9% 0.40% 1.2%
isons among women in the same WHI component (clinical trial or observational
study) and same five-year age category. Since we are not using time-to-event
methods, we do not stratify on length of enrollment but rather compare out-
comes across the entire follow-up period, which averages 8.19 years for treated
women and 8.08 years for control women. Women in the control group were
observed for about 1.3% less time, a difference that is too small to matter here.
For reweighting, we opt to use the maximum entropy reweighting approach
described by Hartman et al. (2013) – again, trying to reduce the assumptions
we place on the data. We select the same set of confounding factors used in
Prentice et al. (2005) as our variables on which to conduct maximum entropy
reweighting. The authors computed separate hazard ratios for different levels
of these variables, exemplifying the belief that the causal effect may vary based
on them.
A naive difference between the frequency of CHD events in the treated versus
control populations of the RCT gold dataset yields a causal effect of 0.67%.
Age stratification and maximum entropy reweighting, as implemented using the
ebal package (Hainmueller, 2014), yield substantially similar quantities. This
indicates that combined hormone therapy increases the frequency of coronary
heart disease. Inspection reveals that the women in the RCT have higher BMIs,
are more likely to smoke, and went through menopause younger, all of which
have a negative interaction effect with HT on coronary heart disease.
5.4 Prognostic modeling
At the end of Section 2.2 we mentioned a strategy of subdividing propensity
bins on a prognostic measure that predicts potential outcomes, in order to make
Assumption 4 more reasonable. The spiked-in estimator works best for small
values of ∆k, that is when the mean potential outcome vector (Yit, Yic) is nearly
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Table 12: Standardized differences (SD) between treated and control popula-
tions in RCT gold dataset, for smoking category.
Never Smoked Past Smoker Current Smoker SD
Treated 50.1% 38.7% 11.2%
0.03
Control 50.6% 39.1% 10.2%
the same for both ODB and RCT subjects within each stratum. In this section
we develop such a stratification for the WHI data using a prediction of CHD. We
subdivide the propensity based strata by a predicted value for E(Yic) derived
from the ODB control population. We refer to this as the “prognostic score.”
Since the CHD outcome is binary, we use logistic regression to predict Yic.We
use the same 684 covariates obtained earlier, and fit the model via forward
stepwise selection, allowing a maximum of 25 variables into the model (this cap
is imposed purely to speed up computation). The model coefficients are derived
using only the data from the observational control population. Selecting only
control women for our training set is sensible, since our goal is to estimate
Yic; we use the ODB only because this dataset is sufficiently large for stable
coefficient estimation. The model achieves a 77.8% (cross-validated) AUC in
the ODB control population. It also has a 73.7% AUC in the RCT gold control
population, though we would not see that in an application. See Figure 6.
To evaluate comparability between the RCT and ODB data before and af-
ter stratification on the prognostic score, we again make use of standardized
differences. We separately evaluate the treated and control groups, looking at
standardized differences between the RCT and ODB populations with CHD
as the outcome. Strata are weighted according to the proportion of the ODB
population within them.
Because the CHD outcome is rare, the distribution of prognostic scores is
highly right-skewed. We thus use equal-depth stratification, rather than the
equal-width stratification used for the propensity score. Since we are already
using ten propensity score strata, we seek to sub-stratify on relatively few ad-
ditional prognostic score bins so as not to reduce sample sizes too dramatically.
We find that prognostic score stratification does not yield an improvement
in comparability. But if we use three prognostic score strata, the standardized
differences are nonetheless within acceptable ranges with and without outcome
score stratification. Among control women, we obtain a standardized difference
of −0.02 when stratifying on the propensity score only. The difference grows
slightly when we additionally stratify on the outcome score to −0.03. The
analogous numbers for the treated women are −0.09 when stratifying only on
the propensity score, and −0.10 when stratifying on both.
5.5 Results
We compared these methods under two scenarios: a small RCT of just 1, 000
units; and a full-sized RCT the size of our silver dataset (8, 269 units). To
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Figure 6: ROC AUC scores for logistic regression outcome model in the control
populations of the ODB and RCT silver datasets.
induce variation, we draw 100 bootstrap replicates, resampling the entire ODB
and resampling RCTs of each size. In each replicate we computed all of our
estimators of the causal effect of HT on CHD.
Boxplots of those estimates appear in Figure 7, with the “gold standard”
age-stratified, reweighted effect of 0.26% from Section 5.3 given by a horizontal
gold line. There is a bias-variance tradeoff among these methods. Figure 8
shows their root mean square errors with respect to the gold standard estimate.
At both sample sizes, the spiked and dual-spiked estimates come out best.
The RCT-only estimator has small bias but very large variance. This stems
from the small size of the RCT silver dataset: just over 8,000 women vs. over
50,000 in the ODB dataset. The naive ODB estimator (unstratified) has the
smallest variance but very large bias giving it the largest RMSE of all the
methods. This stems from the selection bias we have discussed. Stratifying
the ODB data on the propensity score (using 10 equal-width bins), corrects for
much of the bias but leaves it with greater bias than the hybrid methods. The
two spiked estimators have relatively low bias and also small variance across the
bootstrap replicates. At the smaller sample size, the dual spiked estimator does
best, owing to lower bias than the spiked estimator. At the larger sample size,
the dual-spiked estimator still has smaller bias, but its variance is larger, such
that the two estimators perform about the same.
The dynamic weighted estimator is not competitive with the two variants
of the spiked estimator, owing to higher variance and much higher bias. This
estimator is more robust to distributional dissimilarity between the RCT and
ODB populations, which, as discussed in the prior section, does not appear to
be an issue in this dataset.
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Figure 7: Causal estimators computed over 100 bootstrap replicates for small
and larger RCT sizes. The three estimators on the left are all computed from a
single dataset, while the right three estimators make use of both the RCT and
ODB data. The dashed gold line is our gold standard estimate.
6 Conclusions
We have developed propensity based methods to merge data from a randomized
controlled trial with data on the same phenomenon from an observational data
base. Our goal is to reduce the root mean squared error in an estimate of the
overall population treatment effect.
The strategies we use are based on the propensity that the RCT data would
have had, had they been in the ODB. The simplest strategy is to spike the RCT
data into the corresponding propensity strata. It works well in theory and in
experiments when the covariate distribution in the RCT matches that of the
ODB. If however those distributions differ sharply, as they could for an RCT
with restrictive enrollments, then the spiked-in estimator can perform very badly
and even be worse than using the ODB alone without the RCT. We developed
an alternative estimator based on taking a weighted average of the ODB and
RCT data within every stratum. An oracle knowing the biases and variances
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Figure 8: Root mean square error when estimating the causal effect of HT on
CHD, across 100 bootstrap replicates for small and large RCT sizes. The gold
standard causal effect is taken to be the age-stratified reweighted estimator, the
magnitude of which is shown via the dashed gold line.
of the ODB and RCT within each stratum could make a principled choice of
weight vector. We developed an estimator that uses the plug-in principle to
estimate that weight vector. On biased examples, it greatly outperformed both
the spike-in estimator and the ODB itself.
We lastly evaluated our estimators on the Women’s Health Initiative dataset,
with the goal of obtaining the causal effect of hormone therapy on coronary
heart disease. We had access to a large observational study, as well as a smaller
randomized controlled trial. Half the RCT data was used to estimate a gold
standard causal effect, and a propensity model was fit to the ODB data to correct
for biases due to confounding. We also generated a variant of the spiked-in
estimator, termed the “dual spiked” estimator, which makes use of stratification
on both the propensity score and an “outcome score” predicting the likelihood of
CHD in an untreated woman. Estimators were evaluated based on their RMSE
for the gold standard causal effect across 100 bootstrap replicates. The dual
spiked estimator performed best, followed closely by the spiked-in estimator.
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These estimators introduced a small amount of bias, but greatly reduced the
variance across bootstrap replicates.
Our conclusion is that the spiked and dual-spiked estimator are the best
choices in many practical examples, as long as the RCT and ODB outcome
distributions are similar conditional on the propensity score. Otherwise, we
prefer the dynamic weighted estimator.
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Appendix
This appendix contains two of the lengthier proofs.
Proof of Theorem 1
First let xt =
∑
i∈SWit and yt =
∑
i∈SWitYit. From Proposition 3,
Eδ
( yt
xt
)
=
yt,0
xt,0
− cov(yt − ρtxt, xt)
x2t,0
with xt,0 = E(xt), yt,0 = E(yt) and ρt = yt,0/xt,0. Next xt,0 = npt and
yt,0 = n(st + µtpt). Therefore ρt = µt + st/pt. By independence of the Wit,
cov(y − ρx, x) =
∑
i∈S
cov(Wit(Yit − ρ),Wit) =
∑
i∈S
(Yit − ρ)pi(1− pi)
= −
∑
i∈S
(Yit − ρ)p2i = O(n),
because |Yit| 6 B. Furthermore, x2t,0 > 2n2 and so
Eδ
( yt
xt
)
= µt +
st
pt
+O
( 1
n
)
.
Applying the same argument to the second term in τˆ establishes equation (16)
for Eδ(τˆ).
Now we turn to the delta method variance, using Proposition 4. By inde-
pendence of Wi,
var(yt − ρtxt) =
∑
i∈S
var(Wi(Yit − ρt)) =
∑
i∈S
pi(1− pi)(Yit − ρt)2 = nStt(S)
and by the same argument, var(yc − ρcxc) = nScc(S). Next
cov(yt − ρtxt, yc − ρcxc) =
∑
i∈S
cov(Wi(Yit − ρt), (1−Wi)(Yic − ρc)) = −nStc(S)
because cov(Wi, 1 − Wi) = −pi(1 − pi). The denominators in Proposition 4
simplify to n2p2t , n
2p2c , and n
2ptpc. Then
varδ
( yt
xt
− yc
xc
)
=
1
n
(Stt
p2t
+
Scc
p2c
− 2−Stc
ptpc
)
completing the proof of (15).
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Proof of Corollary 2
The RCT sampling probabilities are all pr. Theorem 1 applies with  = min(pr, 1−
pr). Because the sampling probability is the same for all subjects i, the covari-
ances st(Rk) and sc(R) from equation (11) vanish, making Eδ(τˆrk) = O(1/nrk).
Next from Theorem 1,
varδ(τˆ) =
1
nrk
(
Stt
p2t
+
Scc
p2c
+ 2
Stc
ptpc
)
with parts defined using S = Rk. Then pt = pr, pc = 1− pr, ρt = µt, ρc = µc,
Stt = [pr(1−pr)/nrk]
∑
i∈Rk(Yit−µt)2, Scc = [pr(1−pr)/nrk]
∑
i∈Rk(Yic−µc)2,
and Stc = [pr(1−pr)/nrk]
∑
i∈Rk(Yit−µt)(Yic−µc). Making these substitutions,
varδ(τˆ) =
1
nrk
(
Stt
p2t
+
Scc
p2c
+ 2
Stc
ptpc
)
=
pr(1− pr)
n2rk
(∑
i∈Rk
(Yit − µt)2
p2r
+
(Yic − µc)2
(1− pr)2 + 2
(Yit − µt)(Yic − µc)
pr(1− pr)
)
=
pr(1− pr)
n2rk
∑
i∈Rk
(
(Yit − µt)(1− pr) + (Yic − µc)pr
pr(1− pr)
)2
=
σ¯2rk
pr(1− pr)nrk
where σ¯2rk = (1/nrk)
∑
i∈Rk [(Yit − µt)(1− pr) + (Yic − µc)pr]2. Under Assump-
tion 4, Yit − µt = Yic − µc and σ¯2rk simplifies as given. Similarly, substituting
pr = 1/2 yields the other given simplification.
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